Authors: Sabatine, MS Januzzi, JL Snapinn, S Theroux, P Jang, IK

Citation: Ms. Sabatine et al., A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris, AM J CARD, 88(5), 2001, pp. 488-492

Authors: Theroux, P Alexander, J Pharand, C Barr, E Snapinn, S Ghannam, AF Sax, FL

Citation: P. Theroux et al., Glycoprotein IIb/IIIa receptor blockade improves outcomes in diabetic patients presenting with unstable angina/non-ST-elevation myocardial infarction- Results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) study, CIRCULATION, 102(20), 2000, pp. 2466-2472

Authors: Swedberg, K Kjekshus, J Snapinn, S

Citation: K. Swedberg et al., Long-term survival in severe heart failure in patients treated with enalapril - Ten year follow-up of CONSENSUS I, EUR HEART J, 20(2), 1999, pp. 136-139